Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Azithromycin/Naproxen

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Dubois MM. Treatment of Campylobacter upsaliensis and Helicobacter canis in twin brothers with XLA. Journal of the Pediatric Infectious Diseases Society 11 (Suppl. 1): S9-S10, Jul 2022. Available from: URL: https://dx.doi.org/10.1093/jpids/piac041.036 [abstract] Dubois MM. Treatment of Campylobacter upsaliensis and Helicobacter canis in twin brothers with XLA. Journal of the Pediatric Infectious Diseases Society 11 (Suppl. 1): S9-S10, Jul 2022. Available from: URL: https://dx.doi.org/10.1093/jpids/piac041.036 [abstract]
Metadaten
Titel
Azithromycin/Naproxen
Lack of efficacy
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55987-y

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Rifampicin